Holen Sie sich die Stockscreener-App
1.536
4.06%
-0.064
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HRTX?
Forum
Prognose
Aktiensplit
Finanzdaten der Heron Therapeutics Inc-Aktie (HRTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
1.28%
34.67
|
34.23 | 31.43 | 31.76 | 29.61 |
| Cost Of Revenue |
14.58%
8.444
|
9.885 | 18.21 | 20.16 | 16.85 |
| Gross Profit |
7.71%
26.23
|
24.35 | 13.23 | 11.60 | 12.76 |
Operating Expenses
|
10.25%
31.02
|
34.57 | 38.16 | 54.01 | 45.82 |
| Benefits Costs and Expenses |
10.25%
31.02
|
34.57 | 38.16 | 74.17 | 62.68 |
| Costs And Expenses |
10.25%
31.02
|
34.57 | 38.16 | 74.17 | 62.68 |
| Operating Income/Loss |
53.05%
-4.798
|
-10.22 | -24.93 | -42.40 | -33.06 |
| Income/Loss From Continuing Operations Before Tax |
1,188%
3.646
|
-0.335 | -6.721 | -42.06 | -32.77 |
| Income/Loss From Continuing Operations After Tax |
70.53%
-3.16
|
-10.72 | -25.01 | -42.06 | -32.77 |
|
Net Income/Loss
|
70.53%
-3.16
|
-10.72 | -25.01 | -42.06 | -32.77 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
3,346%
151.20
|
4.388 | 144.99 | 119.72 | 119.25 |
| Diluted Average Shares |
3,346%
151.20
|
4.388 | 144.99 | 119.72 | 119.25 |
| Basic Earnings Per Share |
60.00%
-0.02
|
-0.05 | -0.17 | -0.35 | -0.27 |
| Diluted Earnings Per Share |
60.00%
-0.02
|
-0.05 | -0.17 | -0.35 | -0.27 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.24%
0.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):